Page last updated: 2024-08-05 15:33:18

hepatic steatosis inducing agent

Any hepatotoxic agent capable of inducing liver steatosis or fatty liver disease.

ChEBI ID: 83612

Members (1)

MemberDefinitionClass
dicarbethoxydihydrocollidineA dihydropyridine that is 2,4,6-trimethyl-1,4-dihydropyridine substituted by ethoxycarbonyl groups at positions 3 and 5.3,5-diethoxycarbonyl-1,4-dihydrocollidine

Research

Studies (319)

TimeframeStudies, Drugs with This Role(%)All Drugs %
pre-199088 (27.59)18.7374
1990's41 (12.85)18.2507
2000's56 (17.55)29.6817
2010's106 (33.23)24.3611
2020's28 (8.78)2.80

Study Types

Publication TypeStudies, Drugs with this Role (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (1.83%)6.00%
Case Studies1 (0.31%)4.05%
Observational0 (0.00%)0.25%
Other320 (97.86%)84.16%

Protein Targets (10)

Potency Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)Drugs
acid sphingomyelinaseHomo sapiens (human)Potency25.118911
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency31.832612
Chain A, Beta-lactamaseEscherichia coli K-12Potency112.202011
chromobox protein homolog 1Homo sapiens (human)Potency89.125111
gemininHomo sapiens (human)Potency23.109311
lamin isoform A-delta10Homo sapiens (human)Potency35.481311
Rap guanine nucleotide exchange factor 4Homo sapiens (human)Potency112.202011
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency19.952611
WRNHomo sapiens (human)Potency22.387211

Inhibition Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)Drugs
Oligo-1,6-glucosidase IMA1Saccharomyces cerevisiae S288CIC5050.000011